Your browser doesn't support javascript.
loading
The predictive validity of a Brain Care Score for late-life depression and a composite outcome of dementia, stroke, and late-life depression: data from the UK Biobank cohort.
Singh, Sanjula D; Rivier, Cyprien A; Papier, Keren; Chemali, Zeina; Gutierrez-Martinez, Leidys; Parodi, Livia; Mayerhofer, Ernst; Senff, Jasper; Clocchiatti-Tuozzo, Santiago; Nunley, Courtney; Newhouse, Amy; Ouyang, An; Westover, M Brandon; Tanzi, Rudolph E; Lazar, Ronald M; Pikula, Aleksandra; Ibrahim, Sarah; Brouwers, H Bart; Howard, Virginia J; Howard, George; Yechoor, Nirupama; Littlejohns, Thomas; Sheth, Kevin N; Rosand, Jonathan; Fricchione, Gregory; Anderson, Christopher D; Falcone, Guido J.
Afiliação
  • Singh SD; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States.
  • Rivier CA; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.
  • Papier K; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Chemali Z; Department of Neurology, Yale School of Medicine, New Haven, CT, United States.
  • Gutierrez-Martinez L; Yale Center for Brain and Mind Health, New Haven, CT, United States.
  • Parodi L; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Mayerhofer E; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States.
  • Senff J; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.
  • Clocchiatti-Tuozzo S; Division of Neuropsychiatry, Massachusetts General Hospital, Boston, MA, United States.
  • Nunley C; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States.
  • Newhouse A; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.
  • Ouyang A; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Westover MB; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States.
  • Tanzi RE; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.
  • Lazar RM; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Pikula A; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Ibrahim S; Department of Neurology, Brigham and Women's Hospitall, Boston, MA, United States.
  • Brouwers HB; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States.
  • Howard VJ; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.
  • Howard G; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Yechoor N; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Littlejohns T; Department of Neurology, Brigham and Women's Hospitall, Boston, MA, United States.
  • Sheth KN; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States.
  • Rosand J; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.
  • Fricchione G; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Anderson CD; Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands.
  • Falcone GJ; Department of Neurology, Yale School of Medicine, New Haven, CT, United States.
Front Psychiatry ; 15: 1373797, 2024.
Article em En | MEDLINE | ID: mdl-39109366
ABSTRACT

Introduction:

The 21-point Brain Care Score (BCS) is a novel tool designed to motivate individuals and care providers to take action to reduce the risk of stroke and dementia by encouraging lifestyle changes. Given that late-life depression is increasingly recognized to share risk factors with stroke and dementia, and is an important clinical endpoint for brain health, we tested the hypothesis that a higher BCS is associated with a reduced incidence of future depression. Additionally, we examined its association with a brain health composite outcome comprising stroke, dementia, and late-life depression.

Methods:

The BCS was derived from the United Kingdom Biobank baseline evaluation in participants with complete data on BCS items. Associations of BCS with the risk of subsequent incident late-life depression and the composite brain health outcome were estimated using multivariable Cox proportional hazard models. These models were adjusted for age at baseline and sex assigned at birth.

Results:

A total of 363,323 participants were included in this analysis, with a median BCS at baseline of 12 (IQR 11-14). There were 6,628 incident cases of late-life depression during a median follow-up period of 13 years. Each five-point increase in baseline BCS was associated with a 33% lower risk of incident late-life depression (95% CI 29%-36%) and a 27% lower risk of the incident composite outcome (95% CI 24%-30%).

Discussion:

These data further demonstrate the shared risk factors across depression, dementia, and stroke. The findings suggest that a higher BCS, indicative of healthier lifestyle choices, is significantly associated with a lower incidence of late-life depression and a composite brain health outcome. Additional validation of the BCS is warranted to assess the weighting of its components, its motivational aspects, and its acceptability and adaptability in routine clinical care worldwide.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article